Gut microbiome composition and dysbiosis in immune thrombocytopenia: A review of literature

• Published in: Blood reviews 2024-09, Vol.67, p.101219, Article 101219
• Main Authors: Saki, Najmaldin, Hadi, Hakimeh, Keikhaei, Bijan, Mirzaei, Arezoo, Purrahman, Daryush
• Format: Article
• Language: English
• Subjects: Dysbiosis - microbiology; Gastrointestinal Microbiome; Humans; Idiopathic thrombocytopenic purpura; Metabolome; Microbiota; Prognosis; Purpura, Thrombocytopenic, Idiopathic - diagnosis; Purpura, Thrombocytopenic, Idiopathic - etiology; Purpura, Thrombocytopenic, Idiopathic - immunology; Purpura, Thrombocytopenic, Idiopathic - microbiology; Therapeutics
• ISSN: 0268-960X; 1532-1681; 1532-1681
• DOI: 10.1016/j.blre.2024.101219

Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by excessive reticuloendothelial platelet destruction and inadequate compensatory platelet production. However, the pathogenesis of ITP is relatively complex, and its exact mechanisms and etiology have not been definitively established. The gut microbiome, namely a diverse community of symbiotic microorganisms residing in the gastrointestinal system, affects health through involvement in human metabolism, immune modulation, and maintaining physiological balance. Emerging evidence reveals that the gut microbiome composition differs in patients with ITP compared to healthy individuals, which is related with platelet count, disease duration, and response to treatment. These findings suggest that the microbiome and metabolome profiles of individuals could unveil a new pathway for aiding diagnosis, predicting prognosis, assessing treatment response, and formulating personalized therapeutic approaches for ITP. However, due to controversial reports, definitive conclusions cannot be drawn, and further investigations are needed.